Article Details

AstraZeneca' Saphnelo Wins FDA Nod For Systemic Lupus Erythematosus, Marking New ...

Retrieved on: 2021-08-02 08:15:00

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca' Saphnelo Wins FDA Nod For Systemic Lupus Erythematosus, Marking New .... View article details on hiswai:

Excerpt

AstraZeneca will pay Bristol-Myers Squibb Co. (NYSE: BMY) a low to mid-teens royalty for sales dependent on geography. Price Action: AZN shares are ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up